Key Differences Summary# Conclusion# Liraglutide represents a meaningful advancement over exenatide across glycemic control (LEAD-6 and DURATION-6 head-to-head superiority), weight management (only agent with FDA obesity approval among the two), cardiovascular outcomes (LEADER superiority vs EXSCEL non-inferiority), and tolerability (less persistent nausea, no injection site nodules, minimal immunogenicity)
Shiau CW, Zhai D, Welsh K, Pinilla C, Nevzi A, Houghten R, Andreeff M , Huang Z, Reed J
Warning: Formulated Supplementary Sports Food
Weve excluded the companies that only offer brand-name drugs from this analysis, as the prices simply arent comparable, and there arent many good reasons to use these companies for branded GLP-1 RAs instead of just going to the doctor if you have insurance
If you take too much of Wegovy or Rybelsus, contact the Poison Help line at 1-800-222-1222 as well as your healthcare provider